Demonstration of Cross-Protective Vaccine Immunity against an Emerging Pathogenic Ebolavirus Species

• Lisa E. Hensley ,

  Contributed equally to this work with: Lisa E. Hensley, Sabue Mulangu

  Affiliation Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, United States of America

  ⨯
• Sabue Mulangu ,

  Contributed equally to this work with: Lisa E. Hensley, Sabue Mulangu

  Affiliation Biodefense Research Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Clement Asiedu,

  Affiliation Biodefense Research Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Joshua Johnson,

  Affiliation Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, United States of America

  ⨯
• Anna N. Honko,

  Affiliation Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, United States of America

  ⨯
• Daphne Stanley,

  Affiliation Biodefense Research Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Giulia Fabozzi,

  Affiliation Biodefense Research Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Stuart T. Nichol,

  Affiliation Special Pathogens Branch, Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• Thomas G. Ksiazek,

  Current address: University of Texas Medical Branch, Galveston National Laboratory, Galveston, Texas, United States of America

  Affiliation Special Pathogens Branch, Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• Pierre E. Rollin,

  Affiliation Special Pathogens Branch, Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• Victoria Wahl-Jensen,

  Affiliation Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, United States of America

  ⨯
• Michael Bailey,

  Affiliation Biodefense Research Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Peter B. Jahrling,

  Affiliation Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Mario Roederer,

  Affiliation Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Richard A. Koup,

  Affiliation Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
•  [ ... ],
• Nancy J. Sullivan

  * E-mail: nsullivan@nih.gov

  Affiliation Biodefense Research Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• [ view all ]
• [ view less ]